1 |
Kang JG, Park C-Y. 2012. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab. J. 36: 13-25.
DOI
|
2 |
Ballinger A, Peikin SR. 2002. Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 440: 109-117.
DOI
|
3 |
Heal D, Aspley S, Prow M, Jackson H, Martin K, Cheetham S. 1998. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from Damphetamine and D-fenfluramine. Int. J. Obes. Relat. Metab. Disord. 22: S18-S28; discussion S9.
|
4 |
Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. 2006. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 29: 277-302.
DOI
|
5 |
Sergent T, Vanderstraeten J, Winand J, Beguin P, Schneider Y-J. 2012. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem. 135: 68-73.
DOI
|
6 |
Maimoona A, Naeem I, Saddiqe Z, Jameel K. 2011. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J. Ethnopharmacol. 133: 261-277.
DOI
|
7 |
Grimm T, Schafer A, Högger P. 2004. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol). Free Radic. Biol. Med. 36: 811-822.
DOI
|
8 |
Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radic. Biol. Med. 27: 704-724.
DOI
|
9 |
Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104: 531-543.
DOI
|
10 |
Virgili F, Kobuchi H, Packer L. 1998. Procyanidins extracted from Pinus maritima (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages. Free Radic. Biol. Med. 24: 1120-1129.
DOI
|
11 |
Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. 1999. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30: 186-195.
DOI
|
12 |
Saliou C, Rimbach G, Moini H, McLaughlin L, Hosseini S, Lee J, et al. 2001. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic. Biol. Med. 30: 154-160.
DOI
|
13 |
Hwang YJ. 2016. Quantitative analysis of taxifolin, (+)-catechin and procyanidin B1 from the preparation of Pinus densiflora (PineXol). Kor. J. Pharmacogn. 47: 246-250.
|
14 |
Go G-W, Srivastava R, Hernandez-Ono A, Gang G, Smith SB, Booth CJ, et al. 2014. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metab. 19: 209-220.
DOI
|
15 |
Sato M, Yamada Y, Matsuoka H, Nakashima S, Kamiya T, Ikeguchi M, et al. 2009. Dietary pine bark extract reduces atherosclerotic lesion development in male ApoE-deficient mice by lowering the serum cholesterol level. Biosci. Biotechnol. Biochem. 73: 1314-1317.
DOI
|
16 |
Nocun M, Ulicna O, Muchova J, Durackova Z, Watala C. 2008. French maritime pine bark extract (Pycnogenol) reduces thromboxane generation in blood from diabetic male rats. Biomed. Pharmacother. 62: 168-172.
DOI
|
17 |
Lee OH, Seo MJ, Choi HS, Lee BY. 2012. Pycnogenol inhibits l ipid a ccumulation i n 3T3- L1 a dipocytes w ith t he modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responses. Phytother. Res. 26: 403-411.
|
18 |
Krisko TI, LeClair KB, Cohen DE. 2017. Genetic ablation of phosphatidylcholine transfer protein/starD2 in ob/ob mice improves glucose tolerance without increasing energy expenditure. Metabolism 68: 145-149.
DOI
|
19 |
Choi J-H, Choi M-K, Han O-T, Han S - J, Chung S-J, Shim C-K, et al. 2007. Evaluation of skin absorption of catechin from topical formulations containing Korean pine bark extract (Pinexol). J. Pharm. Investig. 37: 359-364.
DOI
|
20 |
Hsu CL, Yen GC. 2008. Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Mol. Nutr. Food Res. 52: 53-61.
DOI
|
21 |
Hasegawa N. 2000. Inhibition of lipogenesis by Pycnogenol. Phytother. Res. 14: 472-473.
DOI
|
22 |
Canali R, Comitato R, Schonlau F, Virgili F. 2009. The anti-inflammatory pharmacology of Pycnogenol in humans involves COX-2 and 5-LOX mRNA expression in leukocytes. Int. Immunopharmacol. 9: 1145-1149.
DOI
|
23 |
Bayeta E, Lau BH. 2000. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutr. Res. 20: 249-259.
DOI
|
24 |
Hasegawa N. 1999. Stimulation of lipolysis by Pycnogenol. Phytother. Res. 13: 619-620.
DOI
|
25 |
Ho JN, Kim OK, Nam DE, Jun W, Lee J. 2014. Pycnogenol supplementation promotes lipolysis via activation of cAMP-dependent PKA in ob/ob mice and primary-cultured adipocytes. J. Nutr. Sci. Vitaminol. (Tokyo) 60: 429-435.
DOI
|
26 |
Kim KD, Kim HJ, P ark K- R, Kim S-M, Na Y- C, Shim BS, et al. 2011. Pinexol inhibits in vitro inflammatory biomarkers by blocking signaling pathway and protects mice from lethal endotoxemia. Orient. Pharm. Exp. Med. 11: 61-70.
DOI
|
27 |
Lee YJ, Han OT, Choi H-S, Lee BY, Chung H-J, Lee O-H. 2013. Antioxidant and anti-adipogenic effects of PineXol. Kor. J. Food Sci. Technol. 45: 97-103.
DOI
|
28 |
Chen Y, Sun R, Jiang W, Wei H, Tian Z. 2007. Liver-specific HBsAg transgenic mice are over-sensitive to poly(I: C)-induced liver injury in NK cell- and -dependent manner. J. Hepatol. 47: 183-190.
DOI
|
29 |
Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell W. 1990. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74-80.
DOI
|
30 |
Trevaskis JL, Griffin PS, Wittmer C, Neuschwander-Tetri BA, Brunt EM, Dolman CS, et al. 2012. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302: G762-G772.
DOI
|
31 |
Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, et al. 1999. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig. Dis. Sci. 44: 1249-1253.
DOI
|
32 |
Devaraj S, Vega-Lopez S, Kaul N, Schonlau F, Rohdewald P, Jialal I. 2002. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 37: 931-934.
DOI
|
33 |
Koch R. 2002. Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency. Phytother. Res. 16: 1-5.
|
34 |
Guerrero L, Margalef M, Pons Z, Quiñones M, Arola L, Arola-Arnal A, et al. 2013. Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells. J. Nutr. Biochem. 24: 2092-2099.
DOI
|
35 |
Yang J, Jang J-Y, Nam D-E, Lee J, Hwang K-T, Jun W-J, et al. 2010. Pcynogenol inhibits adipogenesis and simulate antilipogenic effect in 3T3-L1 adipocytes. FASEB J. 24: lb254.
|
36 |
Biddinger SB, Kahn CR. 2006. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68: 123-158.
DOI
|
37 |
Popkin BM, Doak CM. 1998. The obesity epidemic is a worldwide phenomenon. Nutr. Rev. 56: 106-114.
|
38 |
Das U. 2001. Is obesity an inflammatory condition? Nutrition 17: 953-966.
DOI
|
39 |
Kopelman PG. 2000. Obesity as a medical problem. Nature 404: 635-643.
DOI
|